Envestnet Asset Management Inc. Buys 2,781 Shares of Utah Medical Products, Inc. (NASDAQ:UTMD)

Envestnet Asset Management Inc. boosted its stake in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 37.7% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,154 shares of the medical instruments supplier’s stock after buying an additional 2,781 shares during the period. Envestnet Asset Management Inc. owned approximately 0.31% of Utah Medical Products worth $569,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. American Century Companies Inc. increased its holdings in shares of Utah Medical Products by 8.6% in the 4th quarter. American Century Companies Inc. now owns 8,135 shares of the medical instruments supplier’s stock worth $500,000 after purchasing an additional 643 shares in the last quarter. LPL Financial LLC bought a new stake in shares of Utah Medical Products in the 4th quarter worth $208,000. JPMorgan Chase & Co. increased its holdings in shares of Utah Medical Products by 14.8% in the 4th quarter. JPMorgan Chase & Co. now owns 79,703 shares of the medical instruments supplier’s stock worth $4,899,000 after purchasing an additional 10,292 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of Utah Medical Products by 0.9% in the 4th quarter. Geode Capital Management LLC now owns 97,937 shares of the medical instruments supplier’s stock worth $6,022,000 after purchasing an additional 857 shares in the last quarter. Finally, Wells Fargo & Company MN increased its holdings in shares of Utah Medical Products by 24.9% in the 4th quarter. Wells Fargo & Company MN now owns 1,927 shares of the medical instruments supplier’s stock worth $118,000 after purchasing an additional 384 shares in the last quarter. Institutional investors own 69.60% of the company’s stock.

Utah Medical Products Trading Up 0.1%

Utah Medical Products stock opened at $56.84 on Wednesday. The firm has a market cap of $184.73 million, a price-to-earnings ratio of 15.20 and a beta of 0.31. The stock has a fifty day simple moving average of $56.25 and a two-hundred day simple moving average of $56.67. Utah Medical Products, Inc. has a 12 month low of $51.26 and a 12 month high of $69.30.

Utah Medical Products (NASDAQ:UTMD) last released its quarterly earnings results on Thursday, July 24th. The medical instruments supplier reported $0.94 earnings per share (EPS) for the quarter. The firm had revenue of $9.95 million for the quarter. Utah Medical Products had a return on equity of 10.50% and a net margin of 32.34%.

Utah Medical Products Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, October 2nd. Stockholders of record on Wednesday, September 17th will be paid a $0.305 dividend. This represents a $1.22 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date is Wednesday, September 17th. Utah Medical Products’s dividend payout ratio (DPR) is 32.62%.

Utah Medical Products Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.